BTI cells show high levels of DRP1-S579 phosphorylation and targeting DRP1 using RNA interference or pharmacologic inhibition induced apoptosis in BTI cells and inhibited tumor growth [48]. The gene discussed is DNM1L; the disease is neoplasm.